FRAX®: A fracture risk-assessment tool

Aging Health

Volumn 5, Issue 4, 2009, Pages 489-494

  Hamdy, Ronald C ^a  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Fracture risk; Fractures; FRAX ; Osteopenia; Osteoporosis; Risk factors; Treatment thresholds

Indexed keywords

PREDNISOLONE;

ACCURACY; AGE; ALCOHOL ABUSE; BODY MASS; BONE DENSITOMETRY; BONE DENSITY; CIGARETTE SMOKING; CLINICAL ASSESSMENT TOOL; COMPUTER PROGRAM; CORTICOSTEROID THERAPY; FALL RISK ASSESSMENT; FAMILY HISTORY; FEMUR NECK; FRACTURE; FRAGILITY FRACTURE; GENDER; HIP FRACTURE; HUMAN; INJURY SEVERITY; INSTRUMENT VALIDATION; OSTEOPENIA; OSTEOPOROSIS; PATIENT SELECTION; PREDICTION; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SECONDARY OSTEOPOROSIS; TREATMENT RESPONSE;

EID: 70249151069     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/ahe.09.42     Document Type: Review

References (29)

1. Kanis JA, Oden A, Johansson H et al.: FRAX® and its application to clinical practice. Bone 44(5), 732-743 (2009).
2. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E: FRAX® and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 19(4), 385-397 (2008).
3. Siris ES, Delmas PD: Assessment of 10-year absolute fracture risk: a new paradigm with worldwide application. Osteoporos. Int. 19(4), 383-384 (2008).
4. Dawson-Hughes B, Tosteson AN, Melton LJ 3rd et al.: National Osteoporosis Foundation Guide Committee. Osteoporos. Int. 19(4), 449-458 (2008).
5. Klotzbuecher CM Ross PD, Landsman PB, Abbott TA 3rd, Berger M: Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J. Bone Miner. Res. 15(4), 721-739 (2000).
6. Pongchaiyakul C, Nguyen ND, Jones G et al.: Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: a long-term prospective study. J. Bone Miner. Res. 20(8), 1349-1355 (2005).
7. Hamdy RC, Kiebzak GM: Variance in 10-year fracture irsk calculated with and without T-scores in select subgroups of normal and osteoporotic patients. J. Clin. Densitom. 12(2), 158-161 (2009).
8. Ribot C, Temollieres F, Pouilles JM: Can we detect women with low bone mass using clinical risk factors? Am. J. Med. 98(2A), 52S-55S (1995).
9. McClung MR, Geusens P, Miller PD et al.: Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N. Engl. J. Med. 344(5), 333-340 (2001).
10. Riggs BL, Melton LJ, Robb RA et al.: A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J. Bone Miner. Res. 23(2), 205-214 (2008).
11. Chappard C, Houillier P, Paillard M: Bone status in primary hyperparathyroidism. Joint Bone Spine 68(2), 112-119 (2001).
12. Schuit SC, van der Klift M, Weel AE et al.: Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 34(1), 195-202 (2004).
13. Marshall D, Johnell O, Wedel H: Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312(7041), 1254-1259 (1996).
14. Hooven F, Gehlbach SH, Pekow P, Bertone E: Follow-up treatment for osteoporosis alter fracture. Osteoporos. Int. 16(3), 296-301 (2005).
15. Siris ES, Bilezekian JP, Rubin MR: Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J. Clin. Endocrinol. Metab. 88(8), 3482-3486 (2003).
16. Tosi LL, Gliklich R, Kannan K, Koval KJ: The American Orthopaedic Association's 'own the bone' initiative to prevent secondary fractures. J. Bone Joint Surg. Am. 90(1), 163-173 (2008).
17. Bass E, French DD, Bradham DD, Rubenstein LZ: Risk-adjusted mortality rates of elderly veterans with hip fractures. Ann. Epidemiol. 17(7), 514-519 (2007).
18. Johnell O, Kanis JA: An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos. Int. 17(12), 1726-1733 (2006).
19. Pande I, Scott DL, O'Neill TW et al.: Quality of life, morbidity and mortality after low trauma hip fracture in men. Ann. Rheum Dis. 65(1), 87-92 (2006).
20. Wehren LE, Magaziner J: Hip fracture: risk factors and outcomes. Curr. Osteoporos. Rep. 1(2), 78-85 (2003).
21. Cree MW, Juby AG, Carriere KC: Mortality and morbidity associated with osteoporosis drug treatment following hip fracture. Osteoporos. Int. 14(9), 722-727 (2003).
22. Watts NB, Ettinger B, LeBoff MS: FRAX facts. J. Bone. Min. Res. 24(6), 975-979 (2009).
23. Van Staa TP, Geusens P, Kanis JA, Leufkens HG, Gehlbach S, Cooper C: A simple clinical score for estimating the long-term risk of fracture in postmenopausal women. QJM 99(10), 673-682 (2006).
24. Cummings SR, Nevitt MC, Browner WS et al.: Risk factor: for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N. Engl. J. Med. 332, 767 (1995).
25. Johnell O, Oden A, De Laet C et al.: Biochemical indices of bone turnover and the assessment of fracture probability. Osteoporos. Int. 13, 523 (2002).
26. Robbins JA, Schott AM, Garnero P et al.: Risk factors for hip fracture in women with high BMD: EPIDOS study. Osteoporos. Int. 16(2), 149-154 (2005).
27. Tosteson AN, Melton LJ 3rd, Dawson-Hughes B et al.: National Osteoporosis Foundation Guide Committee. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos. Int. 19(4), 437-447 (2008).
28. Faulkner KG: Bone matters: are density increases necessary to reduce fracture risk? J. Bone Miner. Res. 15(2), 183-187 (2000).
29. Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N: The diagnosis of osteoporosis. J. Bone Miner. Res. 9, 1137-1141 (1994).